Taking Advantage of the Factual Nature of the Written Description Requirement to Overcome Rejections
Life sciences patent practitioners know that written description rejections under 35 U.S.C. § 112 for genus claims nearly always refer…
Life sciences patent practitioners know that written description rejections under 35 U.S.C. § 112 for genus claims nearly always refer…
The USPTO examiners use the broadest reasonable interpretation (BRI) when construing claims during examination of patent applications. The BRI standard…
Responding to Conclusory and Unsupported Allegations by USPTO Examiners The USPTO examiners frequently make factual assertions about the technical subject…
Under the America Invents Act (“AIA”), seemingly minor procedural errors made when filing an application can create a procedural morass…
Today the Supreme Court affirmed the Federal Circuit’s decision that IPRs do not violate either Articles III or VII of…
EVE/Inc. and Synopsis, Inc. et al. recently filed a petition for certiorari in the U.S. Supreme Court seeking eradication of…